2o21: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2o21. | {{Seed}} | ||
[[Image:2o21.png|left|200px]] | |||
<!-- | <!-- | ||
Line 9: | Line 10: | ||
{{STRUCTURE_2o21| PDB=2o21 | SCENE= }} | {{STRUCTURE_2o21| PDB=2o21 | SCENE= }} | ||
===Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_17256834}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 17256834 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_17256834}} | |||
==Disease== | ==Disease== | ||
Line 19: | Line 23: | ||
==About this Structure== | ==About this Structure== | ||
2O21 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full | 2O21 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2O21 OCA]. | ||
==Reference== | ==Reference== | ||
Line 51: | Line 55: | ||
[[Category: Complex]] | [[Category: Complex]] | ||
[[Category: Nmr]] | [[Category: Nmr]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 06:09:20 2008'' |
Revision as of 06:09, 29 July 2008
Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligandSolution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand
Template:ABSTRACT PUBMED 17256834
DiseaseDisease
Known disease associated with this structure: Leukemia/lymphoma, B-cell OMIM:[151430]
About this StructureAbout this Structure
2O21 is a Single protein structure of sequence from Homo sapiens. Full experimental information is available from OCA.
ReferenceReference
Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL., Bruncko M, Oost TK, Belli BA, Ding H, Joseph MK, Kunzer A, Martineau D, McClellan WJ, Mitten M, Ng SC, Nimmer PM, Oltersdorf T, Park CM, Petros AM, Shoemaker AR, Song X, Wang X, Wendt MD, Zhang H, Fesik SW, Rosenberg SH, Elmore SW, J Med Chem. 2007 Feb 22;50(4):641-62. Epub 2007 Jan 26. PMID:17256834
Page seeded by OCA on Tue Jul 29 06:09:20 2008
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Pages with broken file links
- Homo sapiens
- Single protein
- Belli, B A.
- Bruncko, M.
- Ding, H.
- Elmore, S W.
- Fesik, S W.
- Joseph, M K.
- Kunzer, A.
- Martineau, D.
- McClellan, W J.
- Mitten, M.
- Ng, S C.
- Nimmer, P M.
- Oltersdorf, T.
- Oost, T K.
- Park, C M.
- Petros, A M.
- Rosenberg, S H.
- Shoemaker, A R.
- Song, X.
- Wang, X.
- Wendt, M D.
- Zhang, H.
- Apoptosis
- Bcl
- Complex
- Nmr